Acumen Pharmaceuticals's total assets for Q3 2024 were $266.98M, a decrease of -7.59% from the previous quarter. ABOS total liabilities were $49.77M for the fiscal quarter, a 10.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.